Skip to main content
SpringerLink
Log in

Generika in Österreich 2003–2008: ein Update

  • Editorial
  • Published:
Wiener klinische Wochenschrift Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  • Frank RG (2007) The ongoing regulation of generic drugs. N Engl J Med 357: 1993–1996

    Article  PubMed  CAS  Google Scholar 

  • CHMP/EMEA (2001) Note for guidance on the investigation of bioavailability and bioequivalence. www.emea.europa.eu/pdfs/human/ewp/140198en.pdf

  • Müller M (2003) Generic drugs – medical progress at a moderate price. Wien Klin Wochenschr 115(1–2): 1–2

    PubMed  Google Scholar 

  • Frantz S (2006) Pharma companies becoming more aggressive towards generic firms. Nat Rev Drug Discov 5: 619–620

    Article  PubMed  CAS  Google Scholar 

  • Snow DB (2007) Maximising the power of generic utilisation: the power of pharmacy benefit management. J Generic Med 5: 27–38

    Article  Google Scholar 

  • Müller M (2006) Biological therapies: concepts and challenges. Wien Klin Wochenschr 118: 508–512

    Article  PubMed  Google Scholar 

  • Belsey MJ, Harris LM, Das RR, Chertkow J (2006) Biosimilars: initial excitement gives way to reality. Nat Rev Drug Discov 5: 535–536

    Article  PubMed  CAS  Google Scholar 

  • Pharmig (2007) Facts and figures 2005. www.pharmig.at/upload/DatenFakten05.pdf

  • Die österreichische Sozialversicherung in Zahlen (2002) 12.A Gebarungsergebnisse der Krankenversicherung. www.sozvers.at/hvb/statistik/ESV_Statistik

  • Gouya G, Reichardt B, Bidner A, Weissenfels R, Wolzt M (2008) Eine differenzierte Rezeptgebühr für Generika erzielt Einsparungen für Kostenträger und Patienten. Wien Klin Wochenschr 120: 89–95

    PubMed  Google Scholar 

  • Tschabitscher D, Platzer P, Baumgärtel C, Müllner M (2008) Generic drugs. Quality, efficacy, safety and interchangeability. Wien Klin Wochenschr 120: 63–69

    PubMed  Google Scholar 

  • Wolzt M, Ohrenberger G, Reichardt B (2003) Kostenreduktion durch projektgeschützte Verschreibung von ACE-Hemmer Generika. Wien Klin Wochenschr 115: 23–28

    Article  PubMed  Google Scholar 

  • Schneeweiss S, Walker AM, Glynn RJ, Maclure M, Dormuth C, Soumerai SB (2002) Outcomes of reference pricing for angiotensin-converting-enzyme inhibitors. N Engl J Med 346: 822–829

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitätsklinik für Klinische Pharmakologie, AKH-Wien, Medizinische Universität Wien/AKH, Wien, Austria

    Markus Müller

Authors
  1. Markus Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Markus Müller.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Müller, M. Generika in Österreich 2003–2008: ein Update. Wien Klin Wochenschr 120, 61–62 (2008). https://doi.org/10.1007/s00508-008-0926-4

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00508-008-0926-4

Keywords

Search

Navigation